(RTTNews) - Solid Biosciences Inc. (SLDB) announced that it has received positive regulatory feedback from a recent Type C meeting with the U.S FDA, marking a key step forward for its gene therapy ...
Roche has dropped five Chugai candidates from its clinical pipeline, echoing actions the Japanese business took earlier this year. Chugai revealed (PDF) the suspension of in-house development of the ...
To detect popular party drugs in human waste, researchers combined headspace solid-phase microextraction and solid-phase microextraction to detect these substances and their metabolites. South Korea ...
BOSTON--(BUSINESS WIRE)--Strand Therapeutics, a leader in next-generation mRNA-based therapeutics, today announced exciting preliminary Phase 1 clinical data for its lead investigational candidate, ...
Phase II assessment of carboplatin with etoposide and high-dose ifosfamide in rEECur, an international randomised controlled trial of chemotherapy for the treatment of recurrent and primary refractory ...
A phase 1 trial of mRNA-4106 has dosed its first patient with an advanced or metastatic solid tumor. The first patient has been dosed with mRNA-4106, a novel pantumor antigen therapy candidate, in a ...
Navy fires USS Mason commanding officer during strike drills Viral AI video of Tom Cruise fighting Brad Pitt leaves Hollywood flabbergasted: 'It's likely over for us' FDA issues highest-level warning ...
Scientists from Nanjing University recently developed a new solid-phase microextraction (SPME)-based system for detecting nitrated polycyclic aromatic hydrocarbons (nitro-PAHs) in aquatic environments ...
A recent article published in Nature Communications described a simultaneous solid-phase recycling and alloying method to address the limitations of traditional alloy recycling through melting. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results